Japan Medical Valuation

JMDMF Stock  USD 3.01  0.00  0.00%   
At this time, the firm appears to be overvalued. Japan Medical Dynamic retains a regular Real Value of $2.6 per share. The prevalent price of the firm is $3.01. Our model calculates the value of Japan Medical Dynamic from evaluating the firm fundamentals such as Return On Equity of 0.0758, current valuation of 177.98 M, and Return On Asset of 0.0496 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
3.01
Please note that Japan Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Japan Medical Dynamic is based on 3 months time horizon. Increasing Japan Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Japan pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Japan Medical Dynamic. Since Japan Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Japan Pink Sheet. However, Japan Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3.01 Real  2.6 Hype  3.01 Naive  3.0
The real value of Japan Pink Sheet, also known as its intrinsic value, is the underlying worth of Japan Medical Dynamic Company, which is reflected in its stock price. It is based on Japan Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Japan Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
2.60
Real Value
3.84
Upside
Estimating the potential upside or downside of Japan Medical Dynamic helps investors to forecast how Japan pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Japan Medical more accurately as focusing exclusively on Japan Medical's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.013.013.01
Details
Hype
Prediction
LowEstimatedHigh
1.773.014.25
Details
Naive
Forecast
LowNext ValueHigh
1.763.004.23
Details

Japan Medical Total Value Analysis

Japan Medical Dynamic is currently expected to have takeover price of 177.98 M with market capitalization of 310.01 M, debt of 1.25 B, and cash on hands of 2.71 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Japan Medical fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
177.98 M
310.01 M
1.25 B
2.71 B

Japan Medical Investor Information

About 43.0% of the company shares are held by company insiders. The company has price-to-book ratio of 1.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Japan Medical Dynamic last dividend was issued on the 30th of March 2023. The entity had 11:10 split on the 28th of May 2002. Japan Medical Dynamic is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.

Japan Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Japan Medical has an asset utilization ratio of 70.19 percent. This implies that the Company is making $0.7 for each dollar of assets. An increasing asset utilization means that Japan Medical Dynamic is more efficient with each dollar of assets it utilizes for everyday operations.

Japan Medical Ownership Allocation

Japan Medical Dynamic has a total of 26.38 Million outstanding shares. Japan Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Japan Medical Profitability Analysis

The company reported the revenue of 19.19 B. Net Income was 2.13 B with profit before overhead, payroll, taxes, and interest of 12.99 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Japan Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Japan Medical and how it compares across the competition.

About Japan Medical Valuation

The pink sheet valuation mechanism determines Japan Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Japan Medical. We calculate exposure to Japan Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Japan Medical's related companies.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company was incorporated in 1973 and is headquartered in Tokyo, Japan. Japan Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 474 people.

8 Steps to conduct Japan Medical's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Japan Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Japan Medical's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Japan Medical's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Japan Medical's revenue streams: Identify Japan Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Japan Medical's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Japan Medical's growth potential: Evaluate Japan Medical's management, business model, and growth potential.
  • Determine Japan Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Japan Medical's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Japan Medical Growth Indicators

Investing in growth stocks can be very risky. If the company such as Japan Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding26.4 M
Quarterly Earnings Growth Y O Y-0.338
Retained Earnings14.6 B

Complementary Tools for Japan Pink Sheet analysis

When running Japan Medical's price analysis, check to measure Japan Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Japan Medical is operating at the current time. Most of Japan Medical's value examination focuses on studying past and present price action to predict the probability of Japan Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Japan Medical's price. Additionally, you may evaluate how the addition of Japan Medical to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm